V. Landré

发表

Polypharmacology of small molecules targeting the ubiquitin–proteasome and ubiquitin-like systems

I. Amelio, V. Landré, R. Knight, 2015, Oncotarget.

Docking-dependent Ubiquitination of the Interferon Regulatory Factor-1 Tumor Suppressor Protein by the Ubiquitin Ligase CHIP*

V. Landré, K. Ball, P. Müller, 2010, The Journal of Biological Chemistry.

p73 promotes glioblastoma cell invasion by directly activating POSTN (periostin) expression

V. Landré, R. Knight, G. Melino, 2016, Oncotarget.

Differential regulated microRNA by wild type and mutant p53 in induced pluripotent stem cells

V. Rotter, V. Landré, G. Melino, 2016, Cell Death and Disease.

Phosphomimetic mutation of the N-terminal lid of MDM2 enhances the polyubiquitination of p53 through stimulation of E2-ubiquitin thioester hydrolysis.

V. Landré, M. Walkinshaw, J. Fraser, 2015, Journal of molecular biology.

Screening for E3-Ubiquitin ligase inhibitors: challenges and opportunities

V. Landré, G. Melino, F. Bernassola, 2014, Oncotarget.

Regulation of transcriptional activators by DNA-binding domain ubiquitination

V. Landré, N. Gilbert, C. Verma, 2017, Cell Death and Differentiation.

Cyclophilin40 isomerase activity is regulated by a temperature-dependent allosteric interaction with Hsp90

B. Erman, V. Landré, M. Walkinshaw, 2015, Bioscience reports.

Protein–Protein Interactions Modulate the Docking-Dependent E3-Ubiquitin Ligase Activity of Carboxy-Terminus of Hsc70- Interacting Protein (CHIP)*□S

V. Landré, M. Walkinshaw, C. Verma, 2019 .

Protein–Protein Interactions Modulate the Docking-Dependent E3-Ubiquitin Ligase Activity of Carboxy-Terminus of Hsc70-Interacting Protein (CHIP)*

V. Landré, M. Walkinshaw, C. Verma, 2015, Molecular & Cellular Proteomics.

DNA-binding regulates site-specific ubiquitination of IRF-1.

V. Landré, D. Xirodimas, K. Ball, 2013, The Biochemical journal.